Head-to-head · Cost-Efficiency Index
Precision Telemed vs Eden
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Precision Telemed
People who want transparent flat pricing on both molecules, all-50 access, and a verified pharmacy.
Visit Precision TelemedEden
People who will trade a higher sticker price for verified nationwide access and stronger clinical oversight.
Visit EdenThe verdict
Precision Telemed takes it, leading the Cost-Efficiency Index 87 to 86. Both molecules at flat, modelable prices nationwide, backed by LegitScript verification — a clean, no-surprises value pick. Eden still earns a B — People who will trade a higher sticker price for verified nationwide access and stronger clinical oversight.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Precision Telemed.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Precision Telemed | Eden |
|---|---|---|
| Cost-Efficiency Index | 87/100 | 86/100 |
| Semaglutide / mo | $149/mo | $239/mo |
| Tirzepatide / mo | $199/mo | $349/mo |
| Semaglutide / yr (modeled) | $1,788 | $2,868 |
| Tirzepatide / yr (modeled) | $2,388 | $4,188 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #8 | #11 |
Precision Telemed
87/100Where the value is
- Both molecules disclosed at flat prices — $149 semaglutide / $199 tirzepatide — easy to model for a year
- Nationwide all-50 coverage
- LegitScript-certified for verified oversight
The tradeoffs
- Compounded only — no brand or oral route
- Mid-market pricing, not the cheapest on the board
Eden
86/100Where the value is
- High transparency — clear supply-chain and clinician disclosure lowers hidden-cost risk
- Nationwide availability with both molecules disclosed
- Strong clinical oversight adds value beyond the raw price
The tradeoffs
- Premium per-month cost drags its normalized value score
- Compounded only — no brand-name access
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.